Benzinga's Top Pre-Market NASDAQ Losers

Orexigen Therapeutics Inc OREX dipped 26.73% to $2.33 in the pre-market session. Orexigen put the further development of its obesity drug candidate Contrave on hold. ARM Holdings plc ARMH dropped 1.47% to $28.06 in the pre-market trading. ARMH's PEG ratio is 3.04. Randgold Resources Limited GOLD fell 0.95% to $80.05 in the pre-market session. Randgold's trailing-twelve-month ROA is 4.83%. VIVUS Inc VVUS moved down 0.82% to $8.47 in the pre-market session. VVUS' PEG ratio is -0.33. Read more from Benzinga's Markets.